Settlement Reached
Settlement Reached
Generic Drug Manufacturers Antitrust Settlement
Glenmark, Lannett, Bausch, Apotex, Heritage and Emcure · Certain generic medications
The multistate antitrust case alleges that generic-drug manufacturers and executives conspired to restrict competition and raise prices for certain generic medications purchased between May 2009 and December 2019. The manufacturers paid $96.5 million into settlement funds, which the states are distributing to eligible consumers.
Case updates and reports
Last updated at
How to participate
Generic Drug Settlement Claim
Consumers who purchased certain generic drugs between May 2009 and December 2019 may check the list of eligible drugs and determine their eligibility for compensation.
- Type
- Settlement Claim
- Claim status
- Open
- Total settlement amount
- $96,500,000
- Payout
- Compensation from the $96.5 million in settlement funds is being distributed to eligible consumers; the article does not state an individual payment amount.
- Reported proof requirement
- Unclear
Sources and links
Generic Drug Antitrust SettlementWKBN · Published